Investor insights
Sectors invested in
Biotechnology3
Therapeutics2
rare disease1
Medical1
Recombinant Prokaryotic Lectins (RPLs)1
Life Science1
Recombinant Protein Production1
Glycoprotein Analysis1
Health Diagnostics1
Health Care1
Viscosity reducers1
Surfactant replacements1
Biophysical characterization1
Subcutaneous formulations1
High concentration1
Antibody formulations1
Parenteral biologics1
New excipient technology1
Protein stabilizers1
engineering enzymes1
Funding rounds participated in
$6.3M sweet spot round size
Most of their 3 investments are in rounds between $529K and $12M
Basic info
Industry
biotechnology research
Sectors
Biotechnology
Process Development
Purification
ultracentrifugation
Biophysical Characterization
cell therapy logisitcs
Cell Therapy
Fermentation
AUC
Health Care
Particle Characterization
Mass Spectrometry
Analytical
Formulation
CHO HCP
Cell Culture
CLD
Release & Stability
Manufacturing
Biopharma
Modeling & Simulation
Date founded
1996
Investments made
R
ReForm Biologics Inc. raised undisclosed on April 4, 2018
Investors: Phoenix Venture Partners LLC and KBI Biopharma
G
GlycoSeLect Ltd raised $529K on October 24, 2017
Investors: Enterprise Ireland and KBI Biopharma
A
Aeglea BioTherapeutics raised $12M on February 6, 2014
Investors: Lilly Ventures, UT Horizon Fund and KBI Biopharma
Funding rounds raised
K
KBI Biopharma raised undisclosed on December 8, 2016
Investors: Innovation Network Corporation Of Japan